ABSTRACT Peptides released from egg proteins via enzymatic hydrolysis show various bioactivities such as antimicrobial, antioxidant, antihypertensive, and immunomodulatory properties. The objective of this study was to investigate the cytotoxic and Angiotensin Converting Enzyme (ACE)-inhibitory activities of ovotransferrin and its promod 278P enzyme hydrolysate. Ovotransferrin from egg white was hydrolyzed using promod 278P at 45
INTRODUCTION
Chicken egg is an important source for proteins, lipids, vitamins, and minerals, and is an excellent source for biologically active substances (Mine, 2007) . Ovotransferrin is the second major protein in egg white, and is well known as an iron-binding protein. The molecular weight of ovotransferrin is 78 kDa and it has 15 disulfide bonds (Ko and Ahn, 2008; Wu and Alexandra, 2012) . It belongs to the transferrin family, which includes serum transferrin and milk lactoferrin (Ibrahim and Kiyono, 2009) . One ovotransferrin molecule can bind 2 iron molecules and transport irons inside the body. Because of its high affinity to ionic iron, ovotransferrin is reported to have antimicrobial activities against a broad spectrum of bacteria, fungi, yeasts, and parasites (Schade and Caroline, 1944; Valenti et al., 1985; Ibrahim, 1997 antioxidant, antiviral, anticancer, and immunomodulatory activities (Xie et al., 2002; Giansanti et al., 2005; Ibrahim et al., 2007) .
Recently, peptides derived from ovotransferrin were reported to have antimicrobial (Ibrahim, 2000) , antihypertensive Majumder and Wu, 2010) , antioxidant (Huang et al., 2010) , and anticancer activities Moon et al., 2013) . It has previously been shown that commercial proteases can hydrolyze ovotransferrin efficiently. Zhang et al. (2011) demonstrated that the antibacterial peptide mixture purified from ovotransferrin by pepsin digest had a strong antibacterial activity, and the minimum inhibitory concentration against Staphylococcus aureus and Escherichea coli was 0.06 and 0.1 mg/mL, respectively. Ibrahim and Kiyono (2009) studied the anticancer, antioxidant, and antimicrobial activities of ovotransferrin hydrolysate and found that the autocleaved ovotransferrin had strong antitumor activities toward colon and breast cancer cells. The enzyme hydrolysates of ovotransferrin showed protective effects against the oxidative stress-induced DNA damage in human leukocytes (Kim et al., 2012) . Lei et al. (2011) reported that peptides derived from ovotransferrin using thermolysin with sonication showed a strong Angiotensin-Converting Enzyme (ACE)-inhibitory activity. The mass spectrometric analysis of the hydrolysate indicated that 99% of the ovotansferrin peptides had mass sizes smaller than 6 kDa and only 1% was larger than 10 kDa. Chiang et al. (2006) reported that the hydrolysis of egg white using thermolysin produced bioactive peptides with high ACE-inhibitory and antioxidant activities. The enzyme suitable for hydrolysis may in principle be any food-grade proteases or protease mixtures from a variety of sources such as plants, animals, or microorganisms like a fungi or bacteria. Suitable proteases are commercially available. Among the food-grade enzymes, promod 278P comprises proteinase from Carica papaya (papain) and proteinases and peptidases from Bacillus subtilis. According to Tester et al. (2007) , promod 278P was particularly effective with respect to extracting the protein from the milled maize. Kim et al. (2012) also reported that ovotransferrin hydrolyzed with commercial enzymes, including promod 278P, possessed significantly lower SC 50 value (effective concentration of ovotransferrin or ovotransferrin hydrolysates required for 50% superoxide anion scavenging activities under the experimental conditions) than the intact ovotransferrin. The objective of this study was to test the ACEinhibitory and cytotoxic activities of promod 278P hydrolysate of ovotransferrin.
MATERIALS AND METHODS

Hydrolysis of Ovotransferrin
The iron-free apo-ovotransferrin used in this study was prepared using the method of Abeyranthne et al. (2013) . Functional peptide was produced from the purified ovotransferrin: Lyophilized ovotransferrin (pH 6.5) was dissolved in distilled water at 20 mg/mL concentration and hydrolyzed at 45
• C for 3 h using promod 278P (E.C. 3.4.24.28, endopeptidase, BISION Corporation, Gyunggi-do, South Korea). Triplicated samples were prepared. The enzyme to substrate ratio was 1:50 (wt/wt) in all replications. At the end of hydrolysis, the enzyme was heat inactivated at 100
• C for 10 min, and then centrifuged at 2,000 × g for 20 min at 4
• C to remove the denatured enzyme. The resulting supernatant was freeze-dried, and the powder was used as the promod 278P hydrolysate of ovotransferrrin. The size of the promod 278P hydrolysate of ovotransferrrin was determined using sodium dodecylsulfate (SDS) electrophoresis. Fifteen percent SDS-PAGE gels were prepared to analyze the peptides derived from ovotransferrin. The SDS-PAGE was conducted under reduced conditions using a Mini-Protein II cell (Bio Rad, Hercules, CA) and stained with Coomassie Brilliant Blue R-250 (Sigma-Aldrich, St. Louis, MO) (Price and Nairn, 2009).
ACE-inhibitory Activity
The antihypertensive effect of protein hydrolysate is normally determined based on its ACE inhibition rate or IC 50 value. A higher ACE inhibition rate or lower IC 50 value indicates a stronger antihypertensive activity. ACE inhibitory activity was determined using the method of Cushman and Cheung (1971) with some modifications. The substrate hippuryhisidyl-leucine (HHL) and angiotensin-converting enzyme (ACE) from rabbit lung were purchased from Sigma-Aldrich.
Testing solutions (40 μL) were incubated with 100 μL of 0.1 M borate buffer (pH 8.3) containing 5 mM HHL (Sigma-Aldrich), 0.3 M NaCl, and 20 μL ACE (2 mU) at 37
• C for 30 minutes. The reaction was stopped by adding 150 μL of 1 M HCl. The hippuric acid formed was extracted with ethyl acetate (1 mL) and centrifuged at 1,500 × g for 10 min, and 750 μL of the organic phase was evaporated. The residue was dissolved in 800 μL of distilled water, and the absorbance was measured at 228 nm (2120 UV; Optizen, Daejon, Korea). The ACEinhibitory activity was expressed as percentage inhibition of ACE activity (%) or expressed as the concentration needed to inhibit 50% of ACE activity (IC 50 ).
ACE − inhibitory activity(%) = 1 − Sample abs. Blank abs. × 100
In vitro Cytotoxicity Test (MTT Assay)
Human normal and cancer cell lines were purchased from the Korean Cell Line Bank (KCLB; Seoul National University, Seoul, Korea). The MCF-7 (human breast adenocarcinoma), HT-29 (human colon adenocarcinoma), and LoVo (human colon adenocarcinoma) cell lines were maintained in RPMI1640 medium (Gibco Laboratories, Grand Island, NY) containing 10% heat-inactivated fetal bovine serum (FBS; HyClone, Logan, UT), penicillin (100 U/mL), and streptomycin (100 μg/mL). HeLa (human cervix adenocarcinoma) and HepG2 (human liver hepatoblastoma) cells were grown in minimum essential medium (MEM) containing 10% heat-inactivated FBS, penicillin, and streptomycin. A normal human lung fibroblastic cell line (MRC-5) was maintained in MEM supplemented with 10% heat-inactivated FBS, penicillin, and streptomycin. All cell lines were cultured at 37
• C in a humidified incubator containing 5% CO 2 . For the cytotoxicity test, cells were seeded in a new t-flask and grown to 80% confluency prior to treatment.
The cytotoxic effects of ovotransferrin and promod 278P hydrolysate of ovotransferrin were determined in vitro using the 3-(4,5-dimethylthizol-2-yl)-2,5-diphenylatetetrazolium bromide [MTT] assay as described by Park et al. (1999) . Briefly, 100 μL aliquots of cell suspension were transferred to a 96-well microplate and incubated for 24 hours. Ovotransferrin and promod 278P hydrolysate of ovotransferrin were then added to each cell suspension, followed by incubation at 37
• C for 44 hours. At the end of the incubation, MTT solution (2.5 mg MTT/mL of phosphate-buffered saline [PBS]) was added, and the plate was incubated for an additional 4 hours. The supernatant was then removed from each cell suspension, and 100 μL of dimethyl sulfoxide was added to dissolve the colored formazan crystals produced from the reaction with MTT. The optical density (OD) of each solution was then measured using a microplate reader at 540 nm (EL311; Bio-Tek Instruments Inc., Seoul, Korea). The concentration required for a 50% inhibition of viability (IC 50 ) was determined graphically (Mosmann, 1983; Carmichael et al., 1987) .
Statistical Analysis
All results were presented as mean ± SE, and statistical analysis was performed using the SPSS (Chicago, IL) package for Windows (version 18.0). The experiments were performed in triplicates and the assays were repeated 3 times (n = 3). The IC 50 value was calculated using Soft Max Pro (version 6.3). The mean values were compared using the one-way ANOVA followed by Duncan's multiple range tests (P < 0.05). Figure 1 shows the SDS-PAGE profiles of natural ovotransferrin and the ovotransferrin hydrolysate using promod 278P. The natural ovotransferrin showed several bands as such: One heavy band near 75 kDa, and the other light bands near 50 and 37 kDa positions. The purity of natural ovotransferrin used was >85% by Image J software calculation (National Institutes of Health, Bethesda, MD). Similar results indicated that unhydrolyzed ovotransferrin sample showed 3 bands as such: One heavy band near 75 kDa marker position, and 2 closely positioned light bands near 50 kDa position (Lei et al., 2011) . The SDS-PAGE of promod 278P enzyme hydrolysate resulted in one clear band at the bottom of the gel (<10 kDa). The promod 278P enzyme hydrolyzed ovotransferrin well and produced peptide with molecular weight <10 kDa (Figure 1 ).
RESULTS AND DISCUSSION
Hydrolysis of Ovotransferrin
ACE-inhibitory Activity
Peptides derived from ovotransferrin were reported to have strong ACE-inhibitory activities . However, nobody has used promod 278P to produce ACE-inhibitory peptides from ovotransferrin. The results showed that the promod 278P hydrolysate of ovotransferrin had stronger ACE-inhibitory activity than the natural ovotransferrin. Increasing the concentration of ovotransferrin from 5 to 20 mg/mL did not increase the ACE-inhibitory activity of ovotransferrin. However, the promod 278P hydrolysate of ovotransferrin showed 76.82 ± 1.28% ACE-inhibitory activity at 10 mg/mL level, and that at 5, 2.5, 1.25, 0.625, and 0.3125 mg/mL levels showed 73.33 ± 2.56%, 56.85 ± 1.84%, 50.32 ± 3.71%, 17.30 ± 0.13%, and 4.52 ± 6.83% ACE-inhibitory activity, respectively. The IC 50 value of promod 278P hydrolysate of ovotransferrin was 1.53 ± 0.20 mg/mL (Figure 2 ). Many ACE-inhibitory peptides have been found in various egg white proteins, including ovotransferrin. Majumder and Wu (2010) reported that treating ovotransferrin with dithiothreitol (DTT) and sonication enhanced the ACE-inhibitory activities of ovotransferrin by 20 times compared with the natural ovotransferrin. They also successfully purified a few potent ACE-inhibitory peptides (IRW, IQW, and LKP) from thermolysin-pepsin hydrolysate of ovotransferrin. Lee et al. (2010) found that treating ovotransferrin with trypsin, acid, and pepsin increased ACE-activity by 60.2, 55.8, and 42.6%, respectively. The enzyme hydrolysates of other egg proteins such as ovalbumin also showed ACE-inhibitory activities: Abeyranthne et al. (2014) reported that ovalbumin hydrolyzed with pepsin produced several peptides with excellent ACE-inhibitory activities. Miguel et al. (2007) reported that the peptides from ovalbumin showed not only ACE-inhibitory activity but also antihypertensive activity in vivo. The ovalbumin hydrolysate showed angiotensin-converting enzyme (ACE) inhibitory activity, one of the most often studied mechanisms underlying the blood pressure-lowering effect of food-derived peptides. Also, the albumin hydrolysate exerted vasodilatory activity in isolated aortic rings before and after digestion. Both activities may explain the antihypertensive effects of the ovalbumin hydrolysate in spontaneously hypertensive rats.
In vitro Cytotoxicity of Ovotransferrin and Promod 278P Hydrolysate of Ovotransferrin
The MTT assay results of ovotransferrin and the promod 278P hydrolysate of ovotransferrin on various cancer cell lines are shown in Figure 3 . The results expressed as IC 50 means the effective concentration of test samples required for 50% cytotoxic activity under the experimental conditions (Table 1) . Most anticancer agents do not differentiate between cancerous and normal cells, leading to systemic toxicity and adverse effects. Therefore, we decided to test both ovotransferrin and the promod 278P hydrolysate of ovotransferrin against normal and cancer cell lines. The cytotoxic effect of ovotransferrin and the promod 278P hydrolysate of ovotransferrin on normal cell (MRC-5) was significantly different from that on human cancer cell lines. At all concentrations tested, both ovotransferrin and promod 278P hydrolysate of ovotransferrin showed <20% cytotoxic activity against MRC-5 cells (data not shown), indicating that neither had cytotoxicity to the normal MRC-5 cells. Figure 3 indicates that increasing the concentration of ovotransferrin from 5 to 20 mg/mL did not increase its cytotoxic activity against all cancer cell lines. However, the enzymatic hydrolysate of ovotransferrin showed significant cytotoxic effects against all cancer cell lines tested. Cytotoxic effects of ovotransferrin and the promod 278P hydrolysate of ovotransferrin to HeLa cells are shown in Figure 3B . The promod 278P hydrolysate of ovotransferrin inhibited the growth of HeLa cells by 80, 94, and 95% at concentrations 5, 10, and 20 mg/mL, respectively ( Figure 3B ). The IC 50 value of the promod 278P hydrolysate of ovotransferrin on HeLa cell was 3.45 mg/mL. Cytotoxic activity was only weakly detected on HepG2 cancer cell after being treated with ovotransferrin (Table 1) . However, the promod 278P hydrolysate of ovotransferrin at 5 mg/mL showed more than 50% cytotoxic activity (54.51%) on HepG2 cancer cell. The IC 50 values of ovotransferrin and the promod 278P hydrolysate of ovotransferrin on HepG2 cells were over 40 mg/mL and 4.43 mg/mL, respectively. Among the cancer cell lines, MCF-7 and LoVo cells were the least sensitive to ovotransferrin and the promod 278P hydrolysate of ovotransferrin ( Figure 3A and 3E). Our previous study indicated that ovotransferrin also has antioxidant, antimicrobial, and cytotoxic activities. However, the enzyme hydrolysates of ovotransferrin showed stronger cytotoxic effects than natural ovotransferrin against human cancer cell lines of various tissue origins, including the lung (A549 and SK-MES-1), stomach (AGS), breast (MCF-7), larynx (Hep-2), cervix (HeLa), and liver (HepG2). Moon et al., 2013) . They also demonstrated that all ovotransferrin hydrolysates at high concentration (e.g., 40 mg/mL) displayed 87.54 to 99.92% cytotoxicity against all cancer cell lines. RacOTf (the reduced autocleaved ovotransferrin) inhibited the proliferation of cancerous MCF-7 and HCT-116 cells in a dose-dependent manner up to 500 μg/mL and then reached a plateau with the greatest effect on HCT-116, but had no effect on normal human mammary epithelial cells (Ibrahim and Kiyono, 2009 ).
CONCLUSION
The promod 278P hydrolysate of ovotransferrin has stronger ACE-inhibitory and cytotoxic activities than ovotransferrin. These results suggest that ovotransferrin-promod 278P hydrolysate can be used as a good natural functional substance for humans.
